Adherence to treatment regimen is associated with improved glycemic control and is particularly problematic during adolescence for those with type 1 diabetes mellitus (T1DM). Both glycemic control and adherence may be negatively impacted by poor psychological outcomes in adolescence, such as depressive symptoms and low hopefulness. The purpose of this study was to examine associations between the mealtime insulin bolus score (BOLUS), a more robust proxy measure of adherence than frequency of blood glucose monitoring or self-report, with depressive symptoms, hope, and hemoglobin A1c (HbA1c). Ninety adolescents completed measures of hope (Children's Hope Scale) and depressive symptoms (Center for Epidemiologic StudiesDepression Scale), as well as lab-based measures of HbA1c and mealtime insulin bolus scores (BOLUS). Higher levels of hope were associated with lower levels of depressive symptoms, more frequent mealtime insulin boluses, and better glycemic control. Higher levels of BOLUS behavior were associated with lower depressive symptoms and better glycemic control. Both BOLUS behavior and hope independently and significantly impacted the relationship between depressive symptoms and HbA1c, suggesting a possible mediation. Since hope and BOLUS were each associated with the relationship between depressive symptoms and glycemic control, following confirmation of this relationship in a longitudinal study, clinics may consider measuring hope and BOLUS among youth with high depressive symptoms and further investigating BOLUS behavior and hope as potential intervention targets to improve glycemic control.
| INTRODUCTION
Type 1 diabetes mellitus (T1DM) is one of the most common chronic illnesses in youth 1 ; it involves complex and demanding treatment. 2 Daily management includes blood glucose checks, insulin administration, carbohydrate counting, and monitoring dietary intake, 2 among other tasks. Adolescence represents a time of adjustment when youth begin to take on more tasks related to T1DM management. It also marks a high-risk period for deteriorations in T1DM self-management 3 and glycemic control. 4 Adolescents with T1DM may experience a number of acute physiological insults due to poor management, including ketoacidosis and hypoglycemia. 5 They are similarly at increased risk for long-term complications such as heart disease and kidney failure. 6 Patient engagement with the T1DM treatment regimen (a.k.a.,
"adherence") is associated with improved glycemic control 7 and is important in preventing long-term diabetes complications. 8, 9 Prior studies of patient engagement in diabetes management have used self-report measures (eg, Self-Care Inventory
10
; Diabetes Behavior Rating Scale
11
; Barriers to Diabetes Adherence
12
), structured interview (eg, Diabetes Self-Management Profile 13 ), or frequency of blood glucose monitoring (BGM) as proxy measures of adherence. 14 These measures can be burdensome to complete 11 and subject to recall bias or inaccuracy. 15 The mealtime insulin bolus score (BOLUS) has been proposed as a more robust proxy measure of adherence that uses objective data from insulin pump downloads to assess mealtime management behaviors, mitigating the need to rely on self-report. 9, 16, 17 The BOLUS measure has previously been shown to be more strongly associated with current and future hemoglobin A1c (HbA1c) than BGM frequency, 16, 17 and to be superior to other methods of measuring adherence to insulin self-administration for youth with insulin pumps. 9 Adolescents with T1DM also experience high rates of negative psychological outcomes [18] [19] [20] [21] that are associated with declines in adolescent adherence to self-management of T1DM. [22] [23] [24] Depressive symptoms in adolescents with T1DM are associated with reduced scores on a modified self-care inventory 25 and less frequent BGM. 26 Higher endorsement of depressive symptoms has been found to predict higher HbA1c values, and adherence has been shown to mediate the relationship between depression and glycemic control. 27 Therefore, one purpose of this study was to further examine associations between psychological outcomes, glycemic control, and adherence using the more robust mealtime insulin BOLUS proxy measure of adherence.
While numerous studies have investigated the relationship between depression and both adherence and glycemic control among youth with T1DM, few studies have investigated the impact of hope.
Hope is defined as "a positive motivational state that is based on an interactively derived sense of successful agency (goal-directed energy) and of successful pathways (planning to meet goals)" (p. 287). 28 In 2 previous studies, hope was significantly associated with selfreported adherence, BGM, and HbA1c in youth. 29, 30 Van Allen et al further found that frequency of BGM significantly mediated the relationships between hope and adherence/glycemic control. 30 Another study found that hope was positively associated with metabolic control and negatively associated with depression among adolescents and young adults with T1DM. 31 However, no studies have evaluated the relationship between hope and mealtime insulin BOLUS scores, or relationships between hope, depressive symptoms, mealtime insulin BOLUS scores, and glycemic control.
Importantly, all of the factors described above fit into Hilliard, 2 | METHODS
| Participants
Families were eligible to participate in a larger study about child and family factors related to adherence if youths were 10 to 16 years old, diagnosed with TIDM for at least 6 months, and English speaking.
Exclusion criteria included diagnosis of developmental delay (ie, autism, cerebral palsy, or intellectual disability) or hospitalization within the last year for a psychological disorder. In the current analyses, we used the subset of youth from this larger sample who were on insulin pump therapy (ie, continuous subcutaneous insulin infusion) and for whom we could calculate BOLUS scores. Those on a multiple daily injection treatment regimen were excluded.
| Procedure
Families were recruited during diabetes clinic visits at 2 large metropolitan hospitals from April 2011 to April 2012. Families that consented to participate signed both consent and assent forms. Youths completed study measures on an iPad, HbA1c was obtained from their medical chart, and insulin pump data were collected from device downloads. Additional demographic information was also extracted from the medical chart to characterize the sample. This study was approved by institutional review boards at both hospitals and families were compensated for study participation.
| Measures

| Youth hope
The Children's Hope Scale (CHS) 33 is a 6-item self-report measure used to assess level of hope in children aged 7 to 16 years. It uses a Likert scale ranging from 1 (none of the time) to 6 (all of the time), resulting in a total score ranging from 6 to 36 with higher scores reflecting greater overall hope. The CHS has documented internal and test-retest reliabilities as well as a valid 2-factor structure. 33 The CHS's 2 factors (agency and pathways) are each composed of 3 items.
Example items include, "I am doing just as well as other kids my age"
(agency) and "When I have a problem, I can come up with lots of ways to solve it" (pathways).
| Youth depression
The Center for Epidemiologic Studies-Depression (CES-D) 34 Scale is 
| Bolus behavior (adherence)
Mealtime insulin bolus scores (BOLUS) have been cited as a proxy measure of adherence in T1DM. 9,16,17 BOLUS scores were calculated using youth's insulin pump records. A point was given for each food-associated mealtime bolus occurring between 0600-1000, 1100-1500, and 1600-2200, for a possible 0 to 3 points per day. Daily BOLUS scores were averaged over a 14-day period to calculate an overall BOLUS score.
| Glycated hemoglobin
HbA1c is a proxy measure of glycemic control that estimates average blood glucose levels over about 3 months. 36 HbA1c values from regular clinic visits were abstracted from the medical chart by the research team. 3 | RESULTS
| Statistical analyses
| Participant characteristics
Of the 139 families that consented/assented for the larger study, 90 youths with T1DM were on insulin pump therapy, completed study measures, and provided both HbA1c and insulin pump data. The majority of the participants were male (N = 51; 56.7%) and Caucasian (N = 79; 87.8%). Youths ranged in age from 10 years to almost 17 years (M = 13.68 years; SD = 1.76) and had been diagnosed with TIDM for an average of 6.01 years (SD = 3.11). Additional demographic characteristics are described in Table 1 .
| Descriptive statistics
The Higher levels of hope were associated with lower levels of depressive symptoms, more frequent mealtime insulin boluses, and better glycemic control (ie, lower HbA1c; see Table 2 ). Depressive symptoms were correlated with less frequent bolusing behavior and poorer glycemic control. Higher levels of bolus behavior were associated with better glycemic control. Increasing age was also associated with less frequent bolusing and worse glycemic control, and was thus included as a covariate in additional analyses. Due to significant correlations between variables of interest, multicollinearity statistics were examined for these variables prior to running regression analyses; all were in the normal range.
| Potential mediation (if confirmed by longitudinal data)
After controlling for age, regression analyses were used to examine whether mealtime insulin bolusing behavior may serve as a potential mediator of the relationship between depressive symptoms and and HbA1c. A Sobel test of significance revealed that this effect was statistically significant (t = 2.75, P = .006).
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Regression analyses controlling for age were additionally used to examine whether hope may serve as a potential mediator of the relationship between depressive symptoms and HbA1c, if confirmed by longitudinal data. Results of these analyses revealed that hope was associated with depressive symptoms ( β = −0.50, P < .001) and
HbA1c ( β = −0.39, P < .001). Depressive symptoms were also independently associated with HbA1c ( β = 0.23, P = .019). A regression analysis in which hope and depressive symptoms were used to predict HbA1c was significant (R 2 = 0.27, F[3,86] = 11.76, P = .001).
The relationship between depressive symptoms and HbA1c was no longer statistically significant ( β = 0.04, P = .68) when controlling for the relationship between hope and HbA1c. A Sobel test of significance revealed that this effect was statistically significant (t = 3.38, P < .001). 37 These significant models are described in Figure 1 as one possible interpretation of these relationships; however, directionality cannot be inferred from this cross-sectional analysis. Regression analyses did not find hope to influence the relationship between BOLUS and HbA1c, or for bolusing behavior to impact the relationship between hope and glycemic control.
| DISCUSSION
This study aimed to provide additional information about the relationships between glycemic control, adherence, and depressive symptoms with 2 novel contributions: (1) the examination of BOLUS as the primary measure of adherence, and (2) the incorporation of hope, a variable that has been minimally researched in T1DM. Similar to previous research in T1DM and this age group, youth in this study demonstrated generally poor glycemic control. 4 Twenty-six percent of youth in this sample also had elevated depressive symptoms, which matches recent findings that almost a third of youth with T1DM are expected to report depressive symptoms. 18 Consistent with previous research, glycemic control was associated with adherence, 25 depressive symptoms, 25, 27 and hope. [29] [30] [31] Children with greater depressive symptoms demonstrated worse glycemic control, but hope and BOLUS were 2 protective factors that suggest further investigation in longitudinal samples to determine if they are mediators of the relationship between depression and HbA1c.
BOLUS was significantly associated with the cross-sectional rela- 30 This discrepancy may be due to differences in the amount of variability in individual BOLUS scores vs BGM, and requires further research using independent samples. Alternatively, the relationship between hope and glycemic control may be better explained by factors that were not the focus of this study, such as self-efficacy, optimism, perceived social support, parenting strategies, or general well-being. 29, 30 Hope was also significantly associated with the cross-sectional relationship between depressive symptoms and glycemic control. The construct of hope includes individual abilities to set goals, sustain motivation toward goals, and recruit supportive resources to reach goals. 28 This type of goal-directedness may be an essential component of diabetes management behaviors that are crucial to improving glycemic control. In one previous study of Brazilian adolescents, hope explained 9% of the variance in HbA1c and 30% of the variance in depressive symptoms, indicating that interventions targeting hopefulness may alter the impact of depressive symptoms on diabetes management up to 30%. 31 However, this previous study did not measure adherence behavior. In other pediatric populations (eg, children with cancer), research demonstrated that changes in hope partially mediated the effects of depression on quality of life. 38 Combined with findings from our current study, these results indicate that in youth with higher depressive symptoms, hope may be a key factor that can help to offset the impact of depressive symptoms on glycemic control.
Depression is common in youth with T1DM 18 and there is positive evidence for treating depression in this population 39 ; however, existing treatments do not always directly affect glycemic control. Strengths of the present study included: (1) the collection of data from a moderately large sample of parent/youth dyads, (2) use of the mealtime insulin BOLUS score, which has been shown to relate more strongly to current and future glycemic control than frequency of glucose monitoring, and (3) the examination of possible protective factors associated with depressive symptoms and glycemic control, which have not previously been analyzed together (eg, hope and BOLUS).
There are also limitations to this study that deserve comment. Findings from this study were cross-sectional so we cannot comment on mediation relationships over time. Future research is needed to establish whether these proposed protective factors serve as mediators in longitudinal data. While BOLUS scores provide a more robust measure of adherence than BGM, 9, 16, 17 this measure captures the frequency of bolusing during discrete and typical mealtimes (eg, morning, afternoon, evening) and does not assess if the insulin dose was appropriate or optimally timed. Future studies may consider linking pump data with other patient-reported outcomes, such as food diaries, to determine if the amount of insulin administered was appropriate to the carbohydrate content of meals and to determine the actual timing of boluses to food intake. This study examined a limited set of factors related to glycemic control in youth with T1DM, so additional variables not included in this study could further explain these relationships (eg, self-efficacy, optimism, perceived social support). Finally, the sample was primarily non-Hispanic White and from the middle to upper socioeconomic status, which may limit generalizability to youth from other racial, ethnic, and socioeconomic backgrounds. Future research is needed to confirm these associations in more diverse populations.
| Conclusions
Over a quarter of our sample exhibited elevated depressive symptoms, and higher levels of depressive symptoms were related to worse glycemic control, less frequent mealtime BOLUS, and lower hope. 
